Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11713-11726
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11713
Table 4 Effects of serum-derived immunoglobulin/protein isolates administration on immune and inflammatory markers
SpeciesModel/indicationImpact of dietary supplementation with SBIRef.
PigETEC K88Reduced expression of TNF-α and IL-8 in the gutBosi et al[44]
PostweaningReduced TNF-α in the colonPeace et al[46]
Reduced IFNγ levels in the ileum and colon day 7, but not day 14 post weaning
RatSEBPrevented the SEB-induced increase in IFN-γ, IL-6, and LTB4 in Peyer's patches and in the mucosaPérez-Bosque et al[69]
Increased anti-inflammatory cytokines (IL-10 and mature TGF-β) in intestinal mucosaPérez-Bosque et al[68]
Reduced SEB-induced increase in cytotoxic lymphocyte populations of γδ-T cells, natural killer cells, and the number of activated T lymphocytes in lamina propria.
MouseMdr1-/- knockout mouse model of spontaneous colitisReduced the percentage of activated Th lymphocytesMoretó et al[48]
Reduced INF-γ and TNF-α expression in the colon
Significantly reduced the expression of cytokines IL-2 and IL-17, chemokines MCP-1 and MIP-1b, and iNOS in the mucosa
Mouse2% DSS-induced IBD modelReduced elevation of IL-1α, IL-4, IL-6, IL-10, MCP-1, and KCJiang et al[67]
Human (HIV+ adults)HIV enteropathyI-FABP fell below baseline in 4/5 patients who continued receiving SBI (P < 0.12) out to 48 wkAsmuth et al[31]
MMP-9/TIMP-1 ratios in subjects were significantly lower than controls at baseline (P < 0.007)
MCP-1 levels decreased in 5/5 patients who continued receiving SBI (P < 0.06) out to 48 wk